XML 32 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Commitments and Contingencies - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 04, 2025
Jul. 03, 2025
Jul. 02, 2025
Jul. 01, 2025
Apr. 13, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2025
May 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Aug. 31, 2004
Accrued Payments                            
Collaboration revenue           $ 0 $ 0 $ 2,000 $ 6,000          
Prepaid expenses and other current assets           747,000   747,000         $ 1,659,000  
Other long-term assets           942,000   942,000         0  
Accounts payable           $ 843,000   $ 843,000         $ 516,000  
Warrant exercise per share           $ 6.08   $ 6.08     $ 4   $ 28.5  
Strategic and advisory services fee       $ 250,000                    
Common stock, shares issued           2,205,846   2,205,846         1,601,252  
Common stock, par value           $ 0.001   $ 0.001         $ 0.001  
Chief Executive Officer [Member]                            
Accrued Payments                            
Annual base salary     $ 275,000                      
Chief Executive Officer [Member] | Stock Options [Member] | Common Stock [Member]                            
Accrued Payments                            
Stock option to purchase shares     130,000                      
Stock option purchase of common stock exercise price     $ 5.06                      
Board of Directors [Member]                            
Accrued Payments                            
Deferred board service fee   $ 37,000     $ 139,000                  
Common stock, shares issued   7,450     38,269                  
R&D Agreement [Member] | Subsequent Event [Member]                            
Accrued Payments                            
Contingency accrual, payments $ 192,000                          
The University of Texas MD Anderson Cancer Center and The Texas A & M University System [Member]                            
Accrued Payments                            
Milestone maximum payment                           $ 4,500,000
The University of Texas MD Anderson Cancer Center and The Texas A & M University System [Member] | Royalty [Member]                            
Accrued Payments                            
Payment under license agreement               $ 0 0          
The University of Texas MD Anderson Cancer Center [Member]                            
Accrued Payments                            
Accounts payable           $ 285,000   285,000   $ 285,000   $ 262,000 $ 257,000  
Collaboration Agreement with Solasia Pharma KK [Member] | Royalty [Member]                            
Accrued Payments                            
Collaboration revenue             $ 0 2,000 $ 6,000          
M D Anderson License and The 2015 and 2019 Research and Development Agreement [Member]                            
Accrued Payments                            
Clinical expenses           $ 0   $ 28,000